This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Martin Rosenberg, PhD
Development Scientist, CMC API Development at Novo Nordisk


Martin Rosenberg obtained his PhD in chemistry from University of Copenhagen, Denmark in 2012. He joined the group of Prof. Bo W. Laursen at the University of Copenhagen and in 2013 he was awarded the Research Talent prize from The Danish Council of Independent Research (DFF) for his work on design, synthesis, and characterization of red emitting dyes for use in optical sensor materials. Martin has more than six years of experience from the biotechnology and pharmaceutical industries in the field of chemical process research and development. He joined the Novo Nordisk in 2020 as a development scientist in the CMC API Development department. His current work focuses on scale-up of chemical processes and introducing environmental viable processes from early phase development towards productions for clinical studies

Agenda Sessions

  • Entering the Era of SPPS Productions without DMF